New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

USA News Group   News Commentary

Issued on behalf of Avant Technologies Inc.

Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down patient care. Despite Bill Gates' prophecy about AI replacing doctors the real push today is about supercharging physicians not sidelining them. Recent moves by players such as like Avant Technologies, Inc. (OTCQB: AVAI), Amesite Inc. (NASDAQ: AMST), Oracle Corporation (NYSE: ORCL), Clover Health Investments, Corp. (NASDAQ: CLOV), and Alphabet Inc. (NASDAQ: GOOG, GOOGL) are signaling just how fast this transformation is taking hold.

USA News Group logo (PRNewsfoto/USA News Group)

The article continued: Meanwhile, Barclays projects the healthcare AI market will surge at a 30% compound annual growth rate through 2030 , fueled by a wave of new investment across hospitals, insurers, and pharma. A Deloitte survey echoes the optimism, with 71% of healthcare leaders expecting better profits this year as AI tools scale across systems.

Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology

Avant Technologies, Inc. (OTCQB: AVAI) , an emerging leader in AI-driven healthcare innovation, and its JV partner, Ainnova Tech, Inc., (Ainnova) , a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that The Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA) has received the company's submission package requesting a pre-submission meeting with the FDA for its VisionAI platform technology and is now under review.

Ainnova is requesting a pre-submission meeting with the FDA's review team to discuss any questions and/or concerns about its proposed formal submission, including seeking advice to finalize the protocol and obtain agency guidance for a clinical trial of its VisionAI platform in the early detection of diabetic retinopathy. A pre-submission meeting allows companies to clarify regulatory requirements, get feedback on their plans, and potentially avoid delays or issues during the formal review process.

The clinical studies will aim to support an FDA 510(k) submission to obtain clearance from the regulatory agency to market its technology in the U.S.

Ai-nova Acquisition Corp. (AAC) , the company formed by the partnership between Avant and Ainnova to advance and commercialize Ainnova's technology portfolio, including its VisionAI platform and its versatile retinal cameras, has worldwide licensing rights for this portfolio. The licensing rights include the U.S., where the FDA regulates drug and medical device development, so the success of Ainnova's interactions with the FDA are paramount to marketing the technology portfolio in the United States .

"This milestone reflects our two-tiered strategy, rapid deployment in low-regulation markets where VisionAI operates as a screening tool, and simultaneous progress toward FDA clearance for the U.S. market," said Vinicio Vargas , CEO at Ainnova and a member of AAC's Board of Directors. "Entering the U.S. will unlock significant commercial potential, and early engagement with regulators ensures we do so with speed, credibility, and a validated product."

For medical device applicants like Ainnova, the FDA's pre-submission program is useful to determine a clear regulatory pathway for the successful launch of the device, including the number of patients and the number of clinics that will be needed to generate the necessary clinical data for the FDA to make an informed decision on Ainnova's VisionAI platform.

For Avant , the pre-submission meeting will help define a precise budget for the strategic partnership's entire FDA process.

This follows Ainnova's recent strategic alignment with Apollo Hospitals in Southeast Asia , where the Vision AI platform has been cleared for commercial deployment in Brazil , and clinical pilots are being prepared across the Americas. Avant and Ainnova have identified Brazil and the United States as key strategic markets. Ainnova is currently addressing regulatory pathways in Brazil with the support of its MDSAP certification to meet ANVISA requirements, paving the way for rapid market entry.

Ainnova is being guided by global CRO Fortrea ahead of the important pre-submission meeting with the FDA . The goal is to seek 510(k) clearance for Vision AI in detecting diabetic retinopathy, a gateway to broader use across multiple chronic disease categories.

Between FDA progress, high-profile alliances, and a growing international presence, Avant Technologies continues to carve out a niche in the convergence of AI, diagnostics, and preventative care. Investors looking for small-cap exposure to the healthcare AI revolution may want to keep AVAI on the radar as these developments unfold.

CONTINUED… Read this and more news for Avant Technologies Inc.   https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/

Amesite Inc. (NASDAQ: AMST) recently extended HIPAA compliance for its NurseMagic™ platform to cover individual users as well as enterprise clients. Healthcare providers can now safely use NurseMagic™ to store patient data, helping to reduce documentation time while protecting sensitive information.

"Meeting HIPAA requirements for all of our users is a natural extension of what we've already provided to enterprise customers," said Kalie Wortinger , Senior Manager of Engineering at Amesite . "We operate in a highly regulated industry, where protecting sensitive data is essential. This expansion reinforces our commitment to trust, privacy, and long-term value—for individual users, organizations, and their patients."

The platform's flexibility allows users to integrate AI-generated notes into any existing electronic medical record system.

Oracle Corporation (NYSE: ORCL) recently revealed that North York General Hospital is the first hospital in Canada to migrate its electronic health record system to Oracle Cloud Infrastructure (OCI). The move has significantly decreased system latency, improved login and transaction times, and enhanced disaster recovery protections.

" North York General Hospital is on a mission to set new standards for people-centered care through integrated and coordinated patient services across the organization, and its recent migration to OCI provides the foundation required to achieve that goal," said Erin O'Halloran , vice president and Canada market leader, Oracle Health . "Leveraging OCI's regional footprint in Canada to store and process data has helped NYGH bolster its resilience, improve its scalability, and helped it implement strategic approaches to disaster recovery."

These upgrades are helping clinicians work more efficiently and spend more time with patients. By leveraging OCI, NYGH is positioning itself to advance innovation in healthcare through real-time data and AI technologies.

Clover Health Investments, Corp. (NASDAQ: CLOV) recently announced that its subsidiary, Counterpart Health , is partnering with Alphabet Inc. (NASDAQ: GOOG, GOOGL) through Google Cloud to enhance its Counterpart Assistant platform.

"Physicians are often under-resourced and lack access to cutting-edge technologies that can simplify care delivery," said David Tsay , MD, chief medical officer at Counterpart . "Our goal with Counterpart Assistant is to bring all the leading edge tools under one roof, layer them over a single source of normalized data, and give clinicians what they need to make informed decisions—without the burden of fragmented solutions."

By integrating Google Cloud's Vertex AI Search, the platform enables physicians to quickly access unified patient records and receive AI-generated clinical insights. The collaboration is designed to streamline clinical workflows, reduce administrative burdens, and support better outcomes in value-based care.

"Clinicians are spending nearly 28 hours a week on administrative tasks , and 82% are reporting burnout," said Aashima Gupta , global director of Healthcare Strategy & Solutions, Google Cloud . "Gen AI-powered search can help alleviate some of this burden, and Counterpart Health's integration of Vertex AI Search will empower physicians to access critical patient information quickly and efficiently, helping them refocus on what matters most: better patient care."

Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/

CONTACT:
  USA NEWS GROUP
  info@usanewsgroup.com
  (604) 265-2873

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. ("MIQ"). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased in the open market. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Logo: https://mma.prnewswire.com/media/2603685/5292786/USA_News_Group_Logo.jpg

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/new-advances-in-healthcare-ai-could-unlock-billions-in-market-opportunity-302441466.html

SOURCE USA News Group

News Provided by PR Newswire via QuoteMedia

GOOGL
The Conversation (0)
Alphabet Inc.

Alphabet Inc.

Alphabet Inc is a holding company, with Google, the Internet media giant, as a wholly owned subsidiary. Google generates 99% of Alphabet revenue, of which more than 85% is from online ads. Google's other revenue is from sales of apps and content on Google Play and YouTube, as well as cloud service fees and other licensing revenue. Sales of hardware such as Chromebooks, the Pixel smartphone, and smart homes products, which include Nest and Google Home, also contribute to other revenue. Alphabet's moonshot investments are in its other bets segment, where it bets on technology to enhance health (Verily), faster Internet access to homes (Google Fiber), self-driving cars (Waymo), and more. Alphabet's operating margin has been 25%-30%, with Google at 30% and other bets operating at a loss.

Don Saladino, Personal Trainer to Hollywood's A-List, Joins Cizzle Brands as an Advisor

Don Saladino, Personal Trainer to Hollywood's A-List, Joins Cizzle Brands as an Advisor

Hollywood actors, professional athletes, and award-winning musicians alike have all relied on Don Saladino, coach and trainer of over 20 years, to reach their full potential in physical fitness. As an advisor to Cizzle Brands, Mr. Saladino will provide his insights, expertise, and access to his vast professional network for the commercialization and promotion of Cizzle Brands' product lines at a global scale.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Streamplay Studio

Streamplay Studio Enters into Agreement to Acquire North American Indie Gaming Leader, Noodlecake Studios

Streamplay Studio Limited (“Streamplay” or the “Company”) (ASX: SP8), is pleased to announce that it has entered into a binding Share Sale Agreement (“SSA”) to acquire 100% of Noodlecake Studios Inc. (“Noodlecake”), a profitable North American indie gaming company headquartered in Canada, from its parent company Zplay (HK) Technology Co. Limited (“Zplay”). The addition of Noodlecake aligns with Streamplay’s strategic direction, including the recent appointment of Silicon Valley tech advisor Paolo Privitera (ASX: 8 October 2024) to the board of directors, strengthening the Company’s North American and global gaming footprint.

Keep reading...Show less
Toro Energy

Integration of Vanadium into Lake Maitland Uranium Resource Underway to Re-optimise Pit

Toro to integrate vanadium into the Lake Maitland uranium resource, in preparation for scoping study update with re-optimised pit, with potential to increase mining volume and potential production

Toro Energy Limited (ASX: TOE) (‘the Company’ or ‘Toro’) is pleased to announce that it has initiated the work of integrating the new Lake Maitland vanadium resource estimation into the recently updated Lake Maitland uranium resource block model. This work is being undertaken in preparation for an updated scoping study, which is estimated to be completed before the end of the year.

Keep reading...Show less
Troy Minerals Restarts Fieldwork at Tsagaan Zalaa Silica Project in Mongolia

Troy Minerals Restarts Fieldwork at Tsagaan Zalaa Silica Project in Mongolia

(TheNewswire)

Troy Minerals Inc.


Renewed Permitting and Drilling Activities Highlight the Project's Potential as a High-Purity Silica Source

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Tesla cars parked near a Tesla sign with "Tech 5" graphic overlay.

Tech 5: Major Players Release Latest Results, Google's Antitrust Fight Heats Up

This week brought major developments in the tech space as interest rate speculation impacted the market and Alphabet (NASDAQ:GOOGL) saw developments in its high-stakes antitrust battle.

Meanwhile, Motorola Solutions (NYSE:MSI) made waves with new artificial intelligence (AI) integrations, and earnings reports impacted shares of Tesla (NASDAQ:TSLA), IBM (NYSE:IBM) and Intel (NASDAQ:INTC).

Meanwhile, the EU continued its regulatory push against Apple (NASDAQ:APPL) and Meta Platforms (NASDAQ:META).

Read on to dive deeper into this week's top stories.

1. DOJ pushes for radical remedies in Google's antitrust trial

This week, federal attorneys presented possible remedies before Judge Amit Mehta in the Google search antitrust case, following his August 2024 ruling that Google is illegally monopolizing the search market.

The US Department of Justice (DOJ) recommended that Google be forced to share its user data with rivals and advocated for the sale of Google’s Chrome business, arguing that the divestiture would give other companies a fighting chance in the search engine market. As the week progressed, executives from OpenAI, DuckDuckGo, Perplexity and Yahoo said they would consider acquiring Chrome if Mehta were to force a sale.

“Google can compete, but they simply don't want to compete on a level playing field,” DOJ attorney David Dahlquist said during his opening remarks on Monday (April 21). He added, “Google is now fearful of competing against rivals who will only get stronger with the proposed remedies in place.” Dahlquist also called for forward-looking remedies that would prevent future monopolization in the burgeoning field of AI-powered search and related AI services, proposing that Google be banned from making deals with phone manufacturers that make Google Search the default search.


Google’s attorney, John Schmidtlein, said the proposal is “fundamentally flawed” and argued that it is a “wishlist” for competitors that would immediately benefit from technology that Google has spent years developing.

In a blog post on Sunday (April 20), Lee-Anne Mulholland, Google’s vice president of regulatory affairs, wrote, “At trial, we will show how DOJ’s unprecedented proposals go miles beyond the Court’s decision, and would hurt America’s consumers, economy, and technological leadership.” Mulholland contends that the DOJ's antitrust proposals would hinder user access to preferred services, raise costs, slow innovation, jeopardize privacy, impede AI development and undermine the functionality and security of key platforms like Chrome and Android.

Illustrating the challenge that Google's competitors face, Dmitry Shevelenko, head of product for Perplexity AI, said that on on Android devices, the process of setting Perplexity AI as the default AI assistant over Google’s pre-set Gemini is like navigating a “jungle gym." However, he also expressed concern that forcing Google to sell Chrome to a competitor, like OpenAI, could lead to the discontinuation of Chrome’s open-source model, which many developers rely on.

Google presented ongoing arguments that users choose Google Search because of its high-quality results, not as a result of anticompetitive practices. The defense also presented evidence that OpenAI, Microsoft (NASDAQ:MSFT) and Meta have sought deals with Samsung Electronics (KRX:005930) to put their AI chatbots onto Samsung phones.

This week's proceedings laid bare starkly contrasting visions for the future of the search market. The result of the trial will be a pivotal moment and could lead to a major shake-up in the tech world.

2. Motorola to enhance smartphones with multi-partner AI integration

Motorola announced a strategic move on Thursday (April 24) to enhance its smartphones through key partnership agreements with Google, Meta, Microsoft and Perplexity. The company's new deal takes a “best-of-breed” approach by integrating specialized technologies from each partner into Moto AI.

The Perplexity app will be pre-installed on the new Razr series, allowing users to access Perplexity's search and assistant capabilities directly within Moto AI. Other Motorola devices launched after March 3, 2025, will receive this feature via a future update. The deal will make Motorola the first smartphone brand to fully integrate Perplexity.

Besides Perplexity, Motorola's partnership with Google integrates Gemini and Gemini Live models for on-device AI features. Meta's Llama model will enhance on-device processing, providing notification summaries and enabling mixed-reality notifications and app viewing. Microsoft’s Copilot serves as another option for a conversational chatbot.

Motorola introduced its newest lineup of Razr phones on Thursday. They are equipped with four new features that leverage the specific strengths of each partner: Next Move for recommendations, Playlist Studio for curated music, Image Studio for text-to-image generation and Look and Talk (exclusive to Razr 60 Ultra) for hands-free AI activation.

3. Tesla, IBM, Intel and Alphabet release results

This week brought Q1 earnings releases from prominent tech firms Tesla, IBM and Intel.

The market’s reaction to these reports often sets the tone for the broader market sentiment and trading activity, underscoring the intense scrutiny these updates now hold.

Tesla released its report after markets closed on Tuesday (April 22), showing lower-than-expected revenue and earnings. Despite that news, the company's share price moved upward on Wednesday. During an earnings call, CEO Elon Musk said that he will begin reducing his time spent at the White House overseeing the Department of Government Efficiency and spend more time at Tesla, news that likely contributed to this upward momentum.

Musk also highlighted a focused approach to bringing robotaxis to Austin by June, with more cities to follow, alongside piloting automated Cybercab production for next year. While 2025 delivery targets were unspecified, he reaffirmed the affordable vehicle's development and ongoing Full Self-Driving progress.

Conversely, IBM’s stock price fell by over 6 percent on Thursday after the company reported its results after Wednesday’s closing bell; the decline came even after it beat analysts' estimates for both revenue and earnings. This negative reaction has been attributed to a slowdown in IBM’s consulting businesses, sparking concerns about the company’s future growth. Cautious language regarding the economic outlook may have also weighed on investor sentiment.

Tesla and IBM performance, April 22 to 25, 2025.

Tesla and IBM performance, April 22 to 25, 2025.

Chart via Google Finance.

Meanwhile, Intel’s Thursday release of its Q1 results revealed flat revenue and lower earnings per share alongside a lower-than-expected outlook for Q2. The report resulted in a decline in Intel’s stock price, erasing earlier gains that followed a Fortune report that the company planned to lay off 20 percent of its workforce.

Intel and Alphabet performance, April 22 to 25, 2025.

Intel and Alphabet performance, April 22 to 25, 2025.

Chart via Google Finance.

Finally, Alphabet shares rose in after-hours trading following its earnings release on Thursday, closing higher on Friday (April 25) as investors reacted positively to a strong report that revealed increases across the board.

4. EU hits Apple and Meta with DMA fines

The European Union fined Apple and Meta on Wednesday on the grounds that the companies have breached the Digital Markets Act (DMA). Apple was fined 500 million euros after the European Union found that the company imposed restrictions that prevented app developers from informing users about offers available outside of Apple's App Store, thereby breaching the DMA's “anti-steering” obligation. Additionally, the European Commission issued a cease-and-desist order to Apple, giving the iPhone maker 60 days to comply with the DMA.

Meta was fined 200 million euros for allegedly violating the DMA's rules on user consent for data usage with its “pay or consent” model, which requires either personalized advertising or a subscription for ad-free service.

Both companies have said they plan to appeal.

“We have spent hundreds of thousands of engineering hours and made dozens of changes to comply with this law, none of which our users have asked for. Despite countless meetings, the Commission continues to move the goal posts every step of the way,” a representative for Apple told CNN.

Meanwhile, Meta told the Wall Street Journal that the penalties amount to “a multibillion-dollar tariff on Meta while requiring us to offer an inferior service.”

5. Apple plans iPhone manufacturing shift

Apple is reportedly planning a significant shift in its iPhone manufacturing strategy, aiming to move the assembly of iPhones destined for the US market from China to India as early as next year, according to a Thursday report in the Financial Times. This potential move signals a considerable departure from Apple's longstanding dependence on China as its primary iPhone production hub. The impetus behind this strategic realignment is largely attributed to the escalating trade tensions between the US and China, which have compelled numerous multinational corporations to re-evaluate and diversify their global supply chains to mitigate risks.

Apple's efforts to establish a manufacturing footprint in India have been underway for several years, with a gradual increase in iPhone production in the South Asian nation. However, the latest reports suggest a much more ambitious plan. Insiders familiar with the matter have indicated to the Financial Times that Apple's ultimate objective is to transfer its entire iPhone production capacity for the US market to India by the end of 2026.

This would represent a complete overhaul of Apple's current manufacturing arrangement and a major boost to India's aspirations of becoming a global electronics manufacturing center.

Don't forget to follow us @INN_Technology for real-time news updates!

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

Syntheia Reports 20,000 Subscriptions

Syntheia Reports 20,000 Subscriptions

Syntheia Corp. (CSE: SYAI) (Syntheia.ai) ("Syntheia" or the "Company"), a leading provider of conversational AI solutions for inbound telephone call management is pleased to report that subscriptions to our Assistant NLP platform has reached 20,000 subscribers.

"Subscription growth since launch continues to exceed expectations and now stands at 20,000+ subscribers as of today. We are delighted at the rates of subscribers and management will continue to report progress as we look to reach our goal of 100,000 subscriptions by the end of 2025," commented Tony Di Benedetto, Chief Executive Officer.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×